raav2-cbsb-hrpe65
Gene therapyexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2007 (NCT00481546)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Retinoid isomerohydrolaseSupplementation
RPE65 supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- raav2-cbsb-hrpe65
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00481546 | Phase 1 | Jul 1, 2007 | National Eye Institute (NEI), University of Pennsylvania |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Eye Institute (NEI) | Government | 1 | 0 | 1 | 2007 |
| University of Pennsylvania | Academic/Hospital | 1 | 1 | 1 | 2007 |
2 organizations
Page 1 / 1